1. Home
  2. LILAK vs ANIP Comparison

LILAK vs ANIP Comparison

Compare LILAK & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Latin America Ltd. Class C

LILAK

Liberty Latin America Ltd. Class C

HOLD

Current Price

$8.68

Market Cap

1.7B

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$71.46

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LILAK
ANIP
Founded
2017
2001
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
2017
1999

Fundamental Metrics

Financial Performance
Metric
LILAK
ANIP
Price
$8.68
$71.46
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$8.20
$110.00
AVG Volume (30 Days)
1.2M
315.7K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
7.55
419.23
EPS
N/A
2.32
Revenue
$4,442,200,000.00
$206,547,000.00
Revenue This Year
$1.37
$21.01
Revenue Next Year
N/A
$17.59
P/E Ratio
N/A
$30.47
Revenue Growth
N/A
2.47
52 Week Low
$4.75
$69.96
52 Week High
$9.13
$99.39

Technical Indicators

Market Signals
Indicator
LILAK
ANIP
Relative Strength Index (RSI) 59.29 35.89
Support Level $7.38 $70.15
Resistance Level $8.93 $83.20
Average True Range (ATR) 0.25 1.79
MACD -0.01 -0.21
Stochastic Oscillator 94.59 10.32

Price Performance

Historical Comparison
LILAK
ANIP

About LILAK Liberty Latin America Ltd. Class C

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: